AUS
NZ
UK
CA
USA
IND
Omnia Metals Group Ltd (ASX:OM1) has issued 29.1 million shares, 30.4 million quoted options, and 6.4 million performance rights following shareholder approval at its 24 June 2026 General Meeting. The company completed its acquisition of American Antimony Metals LLC through an all-share deal and executed a director placement raising $82,500 before costs. These issuances mark a major capital restructuring for the metals exploration and development firm.
Key Highlights
- On 24 July 2026, Omnia Metals Group Ltd (ASX:OM1) issued 29,125,000 shares, 30,398,335 quoted options, and 6,375,000 performance rights.
- The company issued 25 million shares as payment for acquiring 100% ownership of American Antimony Metals LLC.
- A director placement priced at $0.02 per share raised $82,500 before costs, with free attaching options issued on a 1-for-2 basis.
- Performance rights vest if the company achieves a VWAP of at least $0.03 over 20 consecutive trading days.
- Post-issuance, Omnia's capital structure includes 406.9 million fully paid ordinary shares and 306.8 million quoted options.
- Additional free attaching options from a prior placement are scheduled for issuance by 31 July 2026.
Completion of American Antimony Metals Acquisition via All-Share Transaction
Omnia Metals has finalized its acquisition of 100% of American Antimony Metals LLC, following shareholder approval at the 24 June 2026 General Meeting. The consideration consisted of 25 million fully paid ordinary shares issued on 24 July 2026. This all-share transaction enabled Omnia to conserve cash while gaining assets and operations in the antimony metals sector, a commodity critical for industrial and defence applications. The acquisition significantly expands Omnia's footprint into the North American market and diversifies its portfolio beyond existing operations.
This acquisition aligns with Omnia's strategic goal to develop a diversified metals company with exposure to critical and battery metals. Full ownership of American Antimony Metals grants direct control over antimony production and processing capabilities. Antimony's applications in flame retardants, semiconductors, and advanced batteries underscore its growing industrial demand. The transaction's completion on 24 July 2026 follows necessary shareholder and regulatory approvals.
Director Placement Raises $82,500, Signaling Board Confidence
Omnia completed a director placement raising $82,500 before costs through the issue of 4.125 million fully paid ordinary shares at $0.02 each. Directors subscribed for these shares, reflecting strong board confidence in the company's strategic direction and prospects. This capital injection supports working capital and operational requirements amid significant corporate activity.
Shareholders also approved free attaching quoted options on a 1-for-2 basis, totaling 2.062 million options exercisable at $0.025 until 21 March 2028, trading under ASX code OM1O. These options reduce the effective issue price and offer participants potential upside. The director placement thus provided immediate capital and incentives aligned with the company’s growth objectives.
Lead Manager Compensation Provided via Quoted Options
GTT Ventures Pty Ltd and nominees received 15.835 million quoted options as lead manager fees for the director placement. These options, exercisable at $0.025 until 21 March 2028 and quoted as OM1O, are a standard cash-preserving compensation method. This arrangement aligns the lead manager's interests with share price performance, offering a medium-term incentive.
Director Incentive Options and Performance Rights Foster Long-Term Alignment
Omnia issued 12.5 million director incentive options exercisable at $0.025 until 21 March 2028, approved under Resolutions 8(a)–(c). Additionally, 6.375 million unquoted performance rights were granted to directors under Resolutions 7(a)–(c). These rights vest upon achieving a VWAP of $0.03 over 20 consecutive trading days, converting one-for-one into fully paid shares. This multi-tiered incentive structure aligns director compensation with both short- and long-term shareholder value creation.
Updated Capital Structure and Outstanding Option Issuances
Following the 24 July 2026 issuances, Omnia’s capital comprises 406.895 million fully paid ordinary shares and 306.816 million quoted options exercisable at $0.025 until 21 March 2028. The company also holds 30.25 million unquoted performance rights and 5 million restricted options expiring 28 February 2027. The quoted options represent approximately 75% of shares on issue, indicating potential dilution if exercised.
There remain 37.527 million free attaching options from a 23 April 2026 placement, scheduled for issuance by 31 July 2026. Their issuance will increase the total quoted options beyond 344 million, further diluting equity and potentially impacting earnings per share and share price.
ASX Quotation Applications and Regulatory Filings Progressing
Omnia lodged an Appendix 2A application for quotation of 29.125 million shares and 17.898 million quoted options issued on 24 July 2026, alongside a cleansing notice under section 708A(5)(e) of the Corporations Act 2001 (Cth). Director incentive options and performance rights will be subject to separate Appendix 2A and 3G applications on 27 July 2026. This phased filing approach complies with ASX requirements for different security classes.
These filings ensure compliance with ASX and regulatory frameworks, with detailed disclosures on terms and conditions. For further information, contact Quinton Meyers, Non-Executive Director and Company Secretary, at +61 8 9388 0051.
Strategic Positioning in the Antimony Metals Sector
The acquisition positions Omnia within the strategically vital antimony metals sector, which is gaining importance due to global supply chain concerns and rising industrial demand. Antimony is classified as a critical mineral for its use in flame retardants, electronics, and semiconductors. Omnia's North American operations provide exposure to a stable regulatory environment and proximity to end markets, differentiating it from broader mining companies.
Given the concentrated global supply of antimony, Omnia’s North American production capability offers potential advantages amid geopolitical supply chain shifts. This strategic expansion enhances the company’s commodity and geographic diversification.
Governance and Shareholder Approval
All securities issued on 24 July 2026 were approved at the 24 June 2026 General Meeting via eight resolutions covering acquisition shares, director placement, attaching options, lead manager options, director incentive options, and performance rights. This comprehensive shareholder endorsement reflects strong support for management’s strategic and capital management initiatives.
The governance framework includes performance rights vesting tied to VWAP milestones, ensuring alignment with sustainable share price appreciation and shareholder interests. The detailed disclosures and structured approach demonstrate mature capital and incentive management.
Investor Considerations and Outlook on Capital Management
Investors should note the significant dilution risk from over 306 million quoted options alongside 406.8 million ordinary shares. Full exercise of options would considerably increase equity, potentially impacting earnings per share and share price. The $0.03 VWAP vesting threshold for performance rights represents a 50% premium over the $0.02 placement price, setting a meaningful performance target.
The ongoing capital raising activity and upcoming issuance of 37.527 million free attaching options by 31 July 2026 indicate continued equity financing to support growth and integration of the American Antimony Metals acquisition. Key upcoming milestones include successful ASX quotation of all securities and operational progress related to the acquisition.
